194 related articles for article (PubMed ID: 22750454)
1. Detection of anti-leishmanial effect of the Lucilia sericata larval secretions in vitro and in vivo on Leishmania tropica: first work.
Polat E; Cakan H; Aslan M; Sirekbasan S; Kutlubay Z; Ipek T; Ozbilgin A
Exp Parasitol; 2012 Oct; 132(2):129-34. PubMed ID: 22750454
[TBL] [Abstract][Full Text] [Related]
2. The leishmanicidal effect of Lucilia sericata larval saliva and hemolymph on in vitro Leishmania tropica.
Rahimi S; Khamesipour A; Akhavan AA; Rafinejad J; Ahmadkhaniha R; Bakhtiyari M; Veysi A; Akbarzadeh K
Parasit Vectors; 2021 Jan; 14(1):40. PubMed ID: 33430900
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB/c mice946.
Rahimi S; Rafinejad J; Akhavan AA; Ahmadkhaniha R; Bakhtiyari M; Khamesipour A; Akbarzadeh K
Parasit Vectors; 2023 Feb; 16(1):72. PubMed ID: 36797798
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous leishmaniasis infection in Balb/c mice using a Leishmania tropica strain isolated from Turkey.
Girginkardeşler N; Balcioğlu IC; Yereli K; Ozbilgin A; Ozbel Y
J Parasitol; 2001 Oct; 87(5):1177-8. PubMed ID: 11695390
[TBL] [Abstract][Full Text] [Related]
5. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Glucantime-resistant/tolerant cutaneous leishmaniasis with Lucilia sericata larvae and its larval secretions: The first study in the world.
Erdal P; Zekayi K; Serhat S
Trop Biomed; 2016 Dec; 33(4):668-674. PubMed ID: 33579063
[TBL] [Abstract][Full Text] [Related]
7. Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease.
Lira R; Méndez S; Carrera L; Jaffe C; Neva F; Sacks D
Exp Parasitol; 1998 Jul; 89(3):331-42. PubMed ID: 9676711
[TBL] [Abstract][Full Text] [Related]
8. [Infecting glial cells with antimony resistant Leishmania tropica: A new ex-vivo model].
Zorbozan O; Harman M; Evren V; Erdoğan MA; Kılavuz A; Tunalı V; Çavuş İ; Yılmaz Ö; Özbilgin A; Turgay N
Mikrobiyol Bul; 2018 Jan; 52(1):49-55. PubMed ID: 29642829
[TBL] [Abstract][Full Text] [Related]
9. Anti Leishmania activity of Lucilia sericata and Calliphora vicina maggots in laboratory models.
Sanei-Dehkordi A; Khamesipour A; Akbarzadeh K; Akhavan AA; Mir Amin Mohammadi A; Mohammadi Y; Rassi Y; Oshaghi MA; Alebrahim Z; Eskandari SE; Rafinejad J
Exp Parasitol; 2016 Nov; 170():59-65. PubMed ID: 27567983
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the anti-leishmania activity of Lucilia sericata and Sarconesiopsis magellanica blowfly larval excretions/secretions in an in vitro model.
Laverde-Paz MJ; Echeverry MC; Patarroyo MA; Bello FJ
Acta Trop; 2018 Jan; 177():44-50. PubMed ID: 28982577
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of Lucilia sericata larval excretion/secretion products on Leishmania major under in vitro and in vivo conditions.
Sherafati J; Dayer MS; Ghaffarifar F
Parasit Vectors; 2022 Jun; 15(1):212. PubMed ID: 35710519
[TBL] [Abstract][Full Text] [Related]
12. Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in himachal pradesh, India.
Sharma NL; Mahajan VK; Kanga A; Sood A; Katoch VM; Mauricio I; Singh CD; Parwan UC; Sharma VK; Sharma RC
Am J Trop Med Hyg; 2005 Jun; 72(6):819-24. PubMed ID: 15964970
[TBL] [Abstract][Full Text] [Related]
13. The in vitro and in vivo effects of
Baghbani MR; Rashidi S; Naderi Shahabadi S; Ebrahimi S; Alipour S; Asgari Q; Motazedian MH
J Parasit Dis; 2023 Jun; 47(2):363-368. PubMed ID: 37193496
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of Anti-leishmanial Effects of Bee Products (Honey, Propolis) on Leishmania tropica Promastigotes].
Aksoy T; Sivcan E; Doğan F; Çetin S; Yar TM
Mikrobiyol Bul; 2020 Jul; 54(3):479-489. PubMed ID: 32755522
[TBL] [Abstract][Full Text] [Related]
15. Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro.
Allahverdiyev AM; Abamor ES; Bagirova M; Baydar SY; Ates SC; Kaya F; Kaya C; Rafailovich M
Exp Parasitol; 2013 Sep; 135(1):55-63. PubMed ID: 23792003
[TBL] [Abstract][Full Text] [Related]
16. Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
el-On J; Sulitzeanu A; Schnur LF
Ann Trop Med Parasitol; 1991 Jun; 85(3):323-8. PubMed ID: 1746981
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis.
Rosypal AC; Werbovetz KA; Salem M; Stephens CE; Kumar A; Boykin DW; Hall JE; Tidwell RR
J Parasitol; 2008 Jun; 94(3):743-9. PubMed ID: 18605790
[TBL] [Abstract][Full Text] [Related]
18. The effect of Lucilia sericata- and Sarconesiopsis magellanica-derived larval therapy on Leishmania panamensis.
Cruz-Saavedra L; Díaz-Roa A; Gaona MA; Cruz ML; Ayala M; Cortés-Vecino JA; Patarroyo MA; Bello FJ
Acta Trop; 2016 Dec; 164():280-289. PubMed ID: 27686957
[TBL] [Abstract][Full Text] [Related]
19. [Four cutaneous leishmaniosis case resistant to meglumine antimoniate treatment].
Polat E; Kutlubay Z
Turkiye Parazitol Derg; 2014; 38(3):177-80. PubMed ID: 25308455
[TBL] [Abstract][Full Text] [Related]
20. [An alternative biphasic nutrient medium for the diagnosis of cutaneous leishmaniasis].
Aksoy Gökmen A; Öncel K; Özdemir OA; Pektaş B; Çavuş İ; Güngör S; Uzun B; Kaya S; Karaca Ş; Yula E; Demirci M; Özbilgin A
Mikrobiyol Bul; 2015 Apr; 49(2):266-71. PubMed ID: 26167827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
